Evidence map›Paper›PMID 33255369›Full record

ArticleJournal of clinical medicine2020

Local and Systemic Alterations of the L-Arginine/Nitric Oxide Pathway in Sputum, Blood, and Urine of Pediatric Cystic Fibrosis Patients and Effects of Antibiotic Treatment.

Beatrice Hanusch, Folke Brinkmann, Sebene Mayorandan, Kristine Chobanyan-Jürgens, Anna Wiemers, Kathrin Jansen, Manfred Ballmann, Anjona Schmidt-Choudhury, Alexander Bollenbach, Nico Derichs and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Arginine at the host-pathogen interface.Infection and immunity · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Beatrice HanuschUniversity Hospital of Pediatrics and Adolescent Medicine, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.
Folke BrinkmannUniversity Hospital of Pediatrics and Adolescent Medicine, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.
Sebene MayorandanDepartment of Paediatrics, Hannover Medical School, 30623 Hannover, Germany.
Kristine Chobanyan-JürgensDepartment of Paediatrics, Hannover Medical School, 30623 Hannover, Germany.
Anna WiemersUniversity Hospital of Pediatrics and Adolescent Medicine, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.
Kathrin JansenUniversity Hospital of Pediatrics and Adolescent Medicine, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.
Manfred BallmannUniversity Hospital of Pediatrics and Adolescent Medicine, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.
Anjona Schmidt-ChoudhuryUniversity Hospital of Pediatrics and Adolescent Medicine, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.
Alexander BollenbachInstitute of Toxicology, Core Unit Proteomics, Hannover Medical School, 30623 Hannover, Germany.
Nico DerichsDepartment of Paediatrics, Hannover Medical School, 30623 Hannover, Germany.
Dimitrios TsikasInstitute of Toxicology, Core Unit Proteomics, Hannover Medical School, 30623 Hannover, Germany.ORCID 0000-0001-6320-0956
Thomas LückeUniversity Hospital of Pediatrics and Adolescent Medicine, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.
St. Josef-Hospital · DEMedizinische Hochschule Hannover · DEHeidelberg University · DEUniversitätsmedizin Rostock · DE

Funding

Merck Serono L-Arg-NO-CF-2009
6 · The paper itself

Abstract

Alterations in the L-arginine (Arg)/nitric oxide (NO) pathway have been reported in cystic fibrosis (CF; OMIM 219700) as the result of various factors including systemic and local inflammatory activity in the airways. The aim of the present study was to evaluate the Arg/NO metabolism in pediatric CF patients with special emphasis on lung impairment and antibiotic treatment. Seventy CF patients and 78 healthy controls were included in the study. CF patients (43% male, median age 11.8 years) showed moderately impaired lung functions (FEV1 90.5 ± 19.1% (mean ± SD); 21 (30%) had a chronic

Indexed as

antibioticscystic fibrosisinflammationnitric oxidePseudomonas aeruginosa

Identifiers

PMID33255369
PMCPMC7761143
OpenAlexW3108576210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.